Reporte zur Charge 24P2N

Symptomtext

kinrix was administered to a 8 year old patient; administered on 6/2/2022, IPV:1 DOSE :6/18/2013, IPV:2 DOSE : 8/22/2013; This case was reported by a other health professional via call center representative and described the occurrence of inappropriate age at vaccine administration in a 9-year-old male patient who received DTPa-IPV (Kinrix) (batch number 24P2N, expiry date 7th May 2023) for prophylaxis. Co-suspect products included dtpa-ipv vaccine pre-filled syringe device (Kinrix Pre-Filled Syringe Device) injection syringe for prophylaxis. Previously administered products included IPV (On 18th June 2013 1st dose received) and IPV (On 22 nd Aug 2013 2nd dose received). On 2nd June 2022, the patient received Kinrix and Kinrix Pre-Filled Syringe Device. On 2nd June 2022, unknown after receiving Kinrix and Kinrix Pre-Filled Syringe Device, the patient experienced inappropriate age at vaccine administration and inappropriate schedule of vaccine administered. On an unknown date, the outcome of the inappropriate age at vaccine administration and inappropriate schedule of vaccine administered were unknown. This report is made by GSK without prejudice and does not imply any admission or liability for the incident or its consequences. Additional Information: GSK receipt date: 27-SEP-2022 Reporters comment: The medical assistant reported 2 doses of IPV in 2013 and that the 8 year patient received Kinrix vaccine. The vaccine administration facility was the same as primary reporter. The reporter consent to follow up Additional Supportive information: The 8 year patient received kinrix vaccine and already 2 doses of IPV in 2013, which led inappropriate age at vaccine administered and inappropriate schedule of vaccine administered. Date of birth and age provided by Health Care Professional did not match. Unable to reach Health Care Professional clarify.